vs

Side-by-side financial comparison of FIRST INDUSTRIAL REALTY TRUST INC (FR) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $194.8M, roughly 1.2× FIRST INDUSTRIAL REALTY TRUST INC). FIRST INDUSTRIAL REALTY TRUST INC runs the higher net margin — 75.9% vs 19.4%, a 56.6% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 10.0%). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 8.9%).

First Potomac Realty Trust was a real estate investment trust that invested in industrial properties and business parks in the suburbs of the Washington metropolitan area. In 2017, it was acquired by Government Properties Income Trust.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

FR vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.2× larger
ORGO
$225.6M
$194.8M
FR
Growing faster (revenue YoY)
ORGO
ORGO
+68.1% gap
ORGO
78.1%
10.0%
FR
Higher net margin
FR
FR
56.6% more per $
FR
75.9%
19.4%
ORGO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
8.9%
FR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FR
FR
ORGO
ORGO
Revenue
$194.8M
$225.6M
Net Profit
$147.9M
$43.7M
Gross Margin
Operating Margin
28.1%
Net Margin
75.9%
19.4%
Revenue YoY
10.0%
78.1%
Net Profit YoY
179.7%
469.5%
EPS (diluted)
$1.08
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FR
FR
ORGO
ORGO
Q1 26
$194.8M
Q4 25
$188.4M
$225.6M
Q3 25
$181.4M
$150.9M
Q2 25
$180.2M
$101.0M
Q1 25
$177.1M
$86.7M
Q4 24
$175.6M
$126.7M
Q3 24
$167.6M
$115.2M
Q2 24
$164.1M
$130.2M
Net Profit
FR
FR
ORGO
ORGO
Q1 26
$147.9M
Q4 25
$78.8M
$43.7M
Q3 25
$65.3M
$21.6M
Q2 25
$55.2M
$-9.4M
Q1 25
$48.1M
$-18.8M
Q4 24
$68.4M
$7.7M
Q3 24
$99.4M
$12.3M
Q2 24
$51.3M
$-17.0M
Gross Margin
FR
FR
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
FR
FR
ORGO
ORGO
Q1 26
Q4 25
34.6%
28.1%
Q3 25
37.0%
13.7%
Q2 25
31.7%
-12.5%
Q1 25
31.2%
-30.9%
Q4 24
40.1%
8.1%
Q3 24
62.6%
5.4%
Q2 24
31.8%
-10.7%
Net Margin
FR
FR
ORGO
ORGO
Q1 26
75.9%
Q4 25
41.8%
19.4%
Q3 25
36.0%
14.3%
Q2 25
30.6%
-9.3%
Q1 25
27.2%
-21.7%
Q4 24
39.0%
6.1%
Q3 24
59.3%
10.7%
Q2 24
31.3%
-13.1%
EPS (diluted)
FR
FR
ORGO
ORGO
Q1 26
$1.08
Q4 25
$0.60
$0.31
Q3 25
$0.49
$0.11
Q2 25
$0.42
$-0.10
Q1 25
$0.36
$-0.17
Q4 24
$0.51
$0.05
Q3 24
$0.75
$0.09
Q2 24
$0.39
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FR
FR
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.9B
$300.1M
Total Assets
$5.8B
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FR
FR
ORGO
ORGO
Q1 26
Q4 25
$78.0M
$93.7M
Q3 25
$33.5M
$63.7M
Q2 25
$34.9M
$73.1M
Q1 25
$35.7M
$110.0M
Q4 24
$44.5M
$135.6M
Q3 24
$47.1M
$94.3M
Q2 24
$38.5M
$89.9M
Total Debt
FR
FR
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
FR
FR
ORGO
ORGO
Q1 26
$2.9B
Q4 25
$2.7B
$300.1M
Q3 25
$2.7B
$255.1M
Q2 25
$2.6B
$233.2M
Q1 25
$2.7B
$242.9M
Q4 24
$2.7B
$262.9M
Q3 24
$2.6B
$278.5M
Q2 24
$2.6B
$263.5M
Total Assets
FR
FR
ORGO
ORGO
Q1 26
$5.8B
Q4 25
$5.7B
$598.7M
Q3 25
$5.5B
$509.8M
Q2 25
$5.5B
$461.1M
Q1 25
$5.4B
$467.4M
Q4 24
$5.3B
$497.9M
Q3 24
$5.2B
$446.3M
Q2 24
$5.2B
$443.2M
Debt / Equity
FR
FR
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FR
FR
ORGO
ORGO
Operating Cash FlowLast quarter
$39.4M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FR
FR
ORGO
ORGO
Q1 26
Q4 25
$461.3M
$39.4M
Q3 25
$124.6M
$3.1M
Q2 25
$126.1M
$-32.9M
Q1 25
$88.6M
$-19.9M
Q4 24
$352.5M
$10.9M
Q3 24
$105.5M
$8.7M
Q2 24
$107.7M
$4.7M
Free Cash Flow
FR
FR
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
FR
FR
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
FR
FR
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
FR
FR
ORGO
ORGO
Q1 26
Q4 25
5.85×
0.90×
Q3 25
1.91×
0.14×
Q2 25
2.28×
Q1 25
1.84×
Q4 24
5.15×
1.43×
Q3 24
1.06×
0.71×
Q2 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons